COGNIZANT TECHNOLOGY SOLUTIONS CORP
CTSHAPI behind this page
CTSH Q2 2025 request
Playground key active
/api/financials?ticker=CTSH&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue | 5,245 | 4,850 | +8.1% |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 3,479 | 3,204 | +8.6% |
| Selling, General & Administrative | 810 | 781 | +3.7% |
| Depreciation And Amortization | 139 | 128 | +8.6% |
| Operating Income | 817 | 708 | +15.4% |
Show Business Segments breakouts |
|||
| Communications, Media and Technology · Operating Segments | 115 | 89 | +29.2% |
| Financial Services · Operating Segments | 303 | 274 | +10.6% |
| Healthcare Segment · Operating Segments | 254 | 208 | +22.1% |
| Products and Resources · Operating Segments | 187 | 179 | +4.5% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 859 | 750 | +14.5% |
| Investment Income Interest And Dividend | 23 | 30 | -23.3% |
| Interest Expense | -9 | -10 | +10.0% |
| Foreign Currency Transaction Gain Loss Before Tax | 7 | 1 | +600.0% |
| Other Non-Operating Income (Expense) | 4 | -1 | +500.0% |
| Non-Operating Income (Expense) | 25 | 20 | +25.0% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 842 | 728 | +15.7% |
| Income Tax Expense (Benefit) | -197 | -165 | -19.4% |
| Net Income | 645 | 566 | +14.0% |
| EPS (Basic) | 1.31 | 1.14 | +14.9% |
| EPS (Diluted) | 1.31 | 1.14 | +14.9% |
| Wtd Avg Shares (Basic) | 492 | 497 | -1.0% |
| Wtd Avg Shares (Diluted) | 492 | 498 | -1.2% |
| Revenue | 5,245 | 4,850 | +8.1% |
Show Product Lines breakouts |
|||
| Consulting And Technology Services | 3,389 | 3,074 | +10.2% |
| Consulting And Technology Services · Communication, Media and Technology | 464 | 462 | +0.4% |
| Consulting And Technology Services · Financial Services | 1,099 | 1,021 | +7.6% |
| Consulting And Technology Services · Healthcare Segment | 908 | 863 | +5.2% |
| Consulting And Technology Services · Products and Resources | 918 | 728 | +26.1% |
| Outsourcing Services | 1,856 | 1,776 | +4.5% |
| Outsourcing Services · Communication, Media and Technology | 377 | 354 | +6.5% |
| Outsourcing Services · Financial Services | 448 | 426 | +5.2% |
| Outsourcing Services · Healthcare Segment | 643 | 598 | +7.5% |
| Outsourcing Services · Products and Resources | 388 | 398 | -2.5% |
Show Business Segments breakouts |
|||
| Communication, Media and Technology | 841 | 816 | +3.1% |
| Communication, Media and Technology · Europe | 159 | 169 | -5.9% |
| Communication, Media and Technology · Europe, excluding United Kingdom | 35 | 37 | -5.4% |
| Communication, Media and Technology · Fixed Price Contract | 338 | 339 | -0.3% |
| Communication, Media and Technology · GB | 124 | 132 | -6.1% |
| Communication, Media and Technology · North America | 600 | 568 | +5.6% |
| Communication, Media and Technology · Rest of World | 82 | 79 | +3.8% |
| Communication, Media and Technology · Time And Materials Contract | 454 | 430 | +5.6% |
| Communication, Media and Technology · Transaction or volume-based | 49 | 47 | +4.3% |
| Financial Services | 1,547 | 1,447 | +6.9% |
| Financial Services · Europe | 319 | 288 | +10.8% |
| Financial Services · Europe, excluding United Kingdom | 160 | 150 | +6.7% |
| Financial Services · Fixed Price Contract | 687 | 597 | +15.1% |
| Financial Services · GB | 159 | 138 | +15.2% |
| Financial Services · North America | 1,096 | 1,039 | +5.5% |
| Financial Services · Rest of World | 132 | 120 | +10.0% |
| Financial Services · Time And Materials Contract | 812 | 805 | +0.9% |
| Financial Services · Transaction or volume-based | 48 | 45 | +6.7% |
| Healthcare Segment | 1,551 | 1,461 | +6.2% |
| Healthcare Segment · Europe | 217 | 182 | +19.2% |
| Healthcare Segment · Europe, excluding United Kingdom | 166 | 135 | +23.0% |
| Healthcare Segment · Fixed Price Contract | 750 | 703 | +6.7% |
| Healthcare Segment · GB | 51 | 47 | +8.5% |
| Healthcare Segment · North America | 1,298 | 1,252 | +3.7% |
| Healthcare Segment · Rest of World | 36 | 27 | +33.3% |
| Healthcare Segment · Time And Materials Contract | 495 | 497 | -0.4% |
| Healthcare Segment · Transaction or volume-based | 306 | 261 | +17.2% |
| Products and Resources | 1,306 | 1,126 | +16.0% |
| Products and Resources · Europe | 307 | 275 | +11.6% |
| Products and Resources · Europe, excluding United Kingdom | 159 | 148 | +7.4% |
| Products and Resources · Fixed Price Contract | 638 | 594 | +7.4% |
| Products and Resources · GB | 148 | 127 | +16.5% |
| Products and Resources · North America | 918 | 761 | +20.6% |
| Products and Resources · Rest of World | 81 | 90 | -10.0% |
| Products and Resources · Time And Materials Contract | 580 | 447 | +29.8% |
| Products and Resources · Transaction or volume-based | 88 | 85 | +3.5% |
Show Geography breakouts |
|||
| Europe | 1,002 | 914 | +9.6% |
| Europe, excluding United Kingdom | 520 | 470 | +10.6% |
| GB | 482 | 444 | +8.6% |
| North America | 3,912 | 3,620 | +8.1% |
| Rest of World | 331 | 316 | +4.7% |
Show Contract With Customer Basis Of Pricing breakouts |
|||
| Fixed Price Contract | 2,413 | 2,233 | +8.1% |
| Time And Materials Contract | 2,341 | 2,179 | +7.4% |
| Transaction or volume-based | 491 | 438 | +12.1% |
| Operating Expenses (Q) | — | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 42 | 42 | 0.0% |
| Comprehensive Income | 853 | 572 | +49.1% |
| Other Comprehensive Income | 208 | 6 | +3366.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss | 1 | — | — |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 10 | 7 | +42.9% |
| Accumulated Other Comprehensive Income | 208 | 6 | +3366.7% |
| Accumulated Translation Adjustment | 197 | -1 | +19800.0% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,796 | 2,193 | -18.1% |
| Short-Term Investments | 12 | — | — |
| Accounts Receivable | 4,402 | 3,973 | +10.8% |
| Other Assets Current | 1,396 | 1,067 | +30.8% |
| Total Current Assets | 7,606 | 7,245 | +5.0% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 976 | 1,009 | -3.3% |
Show Geography breakouts |
|||
| Europe | 75 | 80 | -6.2% |
| North America | 319 | 323 | -1.2% |
| Rest of World | 582 | 606 | -4.0% |
| Operating Lease Right-of-Use Assets | 565 | 553 | +2.2% |
| Goodwill | 7,120 | 6,395 | +11.3% |
| Deferred Tax Assets | 1,256 | 1,095 | +14.7% |
| Long Term Investments | 110 | — | — |
| Other Non-Current Assets | 1,008 | 1,068 | -5.6% |
| Total Assets | 20,164 | 18,580 | +8.5% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 1,523 | 1,129 | +34.9% |
| Current Liabilities | |||
| Accounts Payable | 279 | 298 | -6.4% |
| Deferred Revenue | 440 | 391 | +12.5% |
| Short Term Borrowings | 33 | 33 | 0.0% |
| Operating Lease Liability Current | 155 | 148 | +4.7% |
| Accrued Liabilities And Other Liabilities | 2,249 | 2,076 | +8.3% |
| Total Current Liabilities | 3,156 | 2,946 | +7.1% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Credit Agreement · Loans Payable | 33 | 33 | 0.0% |
| Non-Current Liabilities | |||
| Deferred Revenue Noncurrent | 34 | 29 | +17.2% |
| Operating Lease Liabilities | 430 | 466 | -7.7% |
| Deferred Tax Liabilities | 169 | 203 | -16.7% |
| Long-Term Debt | 559 | 590 | -5.3% |
| Other Non-Current Liabilities | 528 | 448 | +17.9% |
| Total Liabilities | 4,876 | 4,682 | +4.1% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Credit Agreement · Loans Payable | 594 | 626 | -5.1% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Additional Paid-In Capital | 14 | 15 | -6.7% |
| Retained Earnings | 15,226 | 14,028 | +8.5% |
| Accumulated Other Comprehensive Income | 43 | -150 | +128.7% |
| Total Stockholders' Equity | 15,288 | 13,898 | +10.0% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss | -16 | — | — |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 13 | 28 | -53.6% |
| Accumulated Other Comprehensive Income | 43 | -150 | +128.7% |
| Accumulated Translation Adjustment | 46 | -178 | +125.8% |
| Additional Paid In Capital | 14 | 15 | -6.7% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 15,226 | 14,028 | +8.5% |
| Total Liabilities & Equity | 20,164 | 18,580 | +8.5% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 275 | 266 | +3.4% |
| Deferred Income Taxes | 9 | -125 | +107.2% |
| Stock-Based Compensation | 90 | 90 | 0.0% |
| Other Non-Cash Items | -15 | 31 | -148.4% |
| Change in Accounts Receivable | -320 | -121 | -164.5% |
| Increase Decrease In Other Operating Assets | -60 | -355 | +83.1% |
| Change in Accounts Payable | -29 | -34 | +14.7% |
| Increase Decrease In Deferred Revenue | -10 | -14 | +28.6% |
| Increase Decrease In Other Operating Liabilities | -388 | -493 | +21.3% |
| Net Cash from Operations | 798 | 357 | +123.5% |
| Investing Activities | |||
| Capital Expenditures | -144 | -158 | +8.9% |
| Proceeds From Sale Of Property Plant And Equipment | 70 | — | — |
| Payments To Acquire Other Investments | -16 | -1 | -1500.0% |
| Proceeds From Sale And Maturity Of Other Investments | 1 | 260 | -99.6% |
| Net Cash from Investing | -89 | -317 | +71.9% |
| Financing Activities | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 33 | 35 | -5.7% |
| Share Repurchases | -577 | -209 | -176.1% |
| Repayments Of Debt Lease And Earnout Obligations | -21 | -50 | +58.0% |
| Repayments Of Long Term Lines Of Credit | -300 | — | — |
| Payments Of Dividends Common Stock | -308 | -301 | -2.3% |
| Net Cash from Financing | -1,173 | -525 | -123.4% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 29 | -39 | +174.4% |
| Net Change in Cash | -435 | -524 | +17.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,796 | 2,193 | -18.1% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.